Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) — Net Asset Quality Index
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a Net Asset Quality Index of 68.7% as of September 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of TL384.37 Million minus total liabilities of TL120.48 Million yields net assets of TL263.88 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read ONCSM current and long-term liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Net Asset Quality Index Over Time (2020–2023)
This chart shows how Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s Net Asset Quality Index has evolved across 4 annual periods from 2020 to 2023. As of September 2024, the index stands at 68.7%, representing net assets of TL263.88 Million against total assets of TL384.37 Million TRY. For live market cap and overall valuation, see ONCSM market cap.
Annual Net Asset Quality Index for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2023)
The table below presents the year-by-year Net Asset Quality Index for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. from 2020 to 2023, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See ONCSM net assets for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (TRY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 68.5% | TL231.70 Million | TL338.31 Million | TL106.61 Million | ▲ +4.4 pp |
| 2022 | 64.1% | TL224.08 Million | TL349.58 Million | TL125.50 Million | ▲ +3.3 pp |
| 2021 | 60.8% | TL78.80 Million | TL129.55 Million | TL50.75 Million | ▲ +3.3 pp |
| 2020 | 57.5% | TL76.02 Million | TL132.13 Million | TL56.11 Million | — |